Puma Biotechnology (PBYI) Precio de Acción, Cotización, Noticias e Historial | Benzinga

Puma Biotechnology Inc (PBYI) Precio de Acción, Cotización, Noticias e Historial

PBYINASDAQ

Trade with Public

Trade with Public

$10.21

0.383.87%

Últ. Act.: Oct 19, 4:40 PM

$10.20

0.373.76%

Panorámica generalNoticias Previsión de beneficios Eventos Precios objetivo Finanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Estadísticas Clave

Apertura

$9.85

Cierre

$10.21

Volumen / Prom.

459.90K / 318.99K

Rango diario

$9.74 - $10.29

Rango de 52 semanas

4.58 - 10.72

Capitalización bursátil

$526.52M

Ratio PER

19.27

Rentabilidad por dividendo

-

Exchange

NASDAQ

RSI

70

Interés en corto

9.68%

Días para cubrir

14.02

Noticias Recientes de Puma Biotechnology Inc

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Puma Biotechnology's Q1 Earnings and Revenues Beat

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Zacks

Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.

Lisa Levin

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.

Lisa Levin

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Lisa Levin

Finanzas

Trimestral

Anual

Nombre

Ingresos Variación
Bruto Variación
EBITDA Variación
EBIT Variación
Beneficios Variación

Flujos de Caja

Flujo de Caja Operativo (TTM)

41.15M

Flujo de Caja de Inversión (TTM)

-16.02M

Flujo de Caja de Financiación (TTM)

-45.34M

Flujo de Caja Libre (TTM)

41.16M

Gasto de Capital (TTM)

-

Cambio Neto en Efectivo (TTM)

-20.22M

Tendencia de los analistas

0

0

0

0

ago

Compra

Mantener

Venta

Venta fuerte

Calificación de analistas

3.5

Mantener

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Métricas de Valoración

Valor Empresarial

$418.34M

Relación P/E (TTM)

19.27

Relación P/E (FWD)

-

Relación PEG (TTM)

-

Relación P/S (TTM)

2.20

Relación P/B (TTM)

3.66

Rendimiento de Ganancias % (TTM)

5.19%

Rendimiento de Ganancias % (FWD)

-

EV / EBITDA (TTM)

9.26

Precio / EBITDA (TTM)

11.27

Precio / Flujo de Caja Libre (TTM)

12.37

Valor Contable / Acción

$2.68

Deuda Empresarial

Deuda Total

-

Deuda a Largo Plazo

-

Emisión de Deuda a Largo Plazo (TTM)

-

Reembolso de Deuda a Largo Plazo (TTM)

-$44.45M

Efectivo Total

$36.54M

Deuda a Capital

0.03

Emisión de Deuda (TTM)

-$44.45M

Reembolso de Deuda (TTM)

-$44.45M